Market Closed -
Hong Kong S.E.
09:08:22 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
27.5
HKD
|
+3.38%
|
|
+17.02%
|
-29.67%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
402,020
|
159,955
|
200,382
|
113,318
|
78,525
|
-
|
-
|
Enterprise Value (EV)
1 |
369,839
|
118,166
|
154,618
|
113,318
|
57,609
|
50,111
|
43,842
|
P/E ratio
|
-16.2
x
|
-143
x
|
525
x
|
52.3
x
|
32.7
x
|
24.8
x
|
19.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
20.7
x
|
5.21
x
|
4.29
x
|
2.12
x
|
1.26
x
|
1.08
x
|
0.94
x
|
EV / Revenue
|
19.1
x
|
3.85
x
|
3.31
x
|
2.12
x
|
0.93
x
|
0.69
x
|
0.52
x
|
EV / EBITDA
|
976
x
|
-90.7
x
|
877
x
|
122
x
|
32.6
x
|
18
x
|
10.3
x
|
EV / FCF
|
101
x
|
40.5
x
|
26.4
x
|
-
|
12.4
x
|
8.04
x
|
5.37
x
|
FCF Yield
|
0.99%
|
2.47%
|
3.79%
|
-
|
8.08%
|
12.4%
|
18.6%
|
Price to Book
|
7.1
x
|
3.89
x
|
4.37
x
|
-
|
1.49
x
|
1.37
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
3,184,367
|
3,194,617
|
3,179,915
|
3,188,615
|
3,189,115
|
-
|
-
|
Reference price
2 |
126.2
|
50.07
|
63.01
|
35.54
|
24.62
|
24.62
|
24.62
|
Announcement Date
|
29/03/21
|
28/03/22
|
22/03/23
|
20/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,842
|
19,383
|
30,682
|
46,736
|
53,530
|
62,111
|
72,716
|
83,929
|
EBITDA
1 |
-
|
378.9
|
-1,303
|
176.3
|
928.2
|
1,766
|
2,782
|
4,237
|
EBIT
1 |
-
|
351.7
|
-1,366
|
35.6
|
894.4
|
1,545
|
2,593
|
4,211
|
Operating Margin
|
-
|
1.81%
|
-4.45%
|
0.08%
|
1.67%
|
2.49%
|
3.57%
|
5.02%
|
Earnings before Tax (EBT)
1 |
-
|
-17,072
|
-901.5
|
695.8
|
2,693
|
2,940
|
3,902
|
4,993
|
Net income
1 |
-971.8
|
-17,234
|
-1,074
|
380.1
|
2,142
|
2,410
|
3,184
|
4,113
|
Net margin
|
-8.96%
|
-88.92%
|
-3.5%
|
0.81%
|
4%
|
3.88%
|
4.38%
|
4.9%
|
EPS
2 |
-
|
-7.800
|
-0.3500
|
0.1200
|
0.6800
|
0.7533
|
0.9922
|
1.274
|
Free Cash Flow
1 |
-
|
3,662
|
2,921
|
5,865
|
-
|
4,656
|
6,237
|
8,161
|
FCF margin
|
-
|
18.89%
|
9.52%
|
12.55%
|
-
|
7.5%
|
8.58%
|
9.72%
|
FCF Conversion (EBITDA)
|
-
|
966.35%
|
-
|
3,327.11%
|
-
|
263.63%
|
224.17%
|
192.61%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
1,542.99%
|
-
|
193.21%
|
195.85%
|
198.42%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/11/20
|
29/03/21
|
28/03/22
|
22/03/23
|
20/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 Q2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
10,605
|
13,638
|
17,044
|
20,225
|
26,511
|
13,160
|
27,110
|
26,420
|
28,988
|
32,172
|
EBITDA
|
-
|
-
|
-771.1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
597.4
|
-808.5
|
1,201
|
-185.6
|
-
|
943.9
|
-243.2
|
-
|
-
|
Operating Margin
|
-
|
4.38%
|
-4.74%
|
5.94%
|
-0.7%
|
-
|
3.48%
|
-0.92%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-556.2
|
377.3
|
318.5
|
-
|
1,831
|
862.1
|
-
|
-
|
Net income
|
-
|
-454.2
|
-618.4
|
223
|
157.1
|
-
|
1,561
|
580.5
|
1,076
|
1,030
|
Net margin
|
-
|
-3.33%
|
-3.63%
|
1.1%
|
0.59%
|
-
|
5.76%
|
2.2%
|
3.71%
|
3.2%
|
EPS
|
-
|
-
|
-
|
0.0700
|
0.0500
|
-
|
0.4900
|
0.1900
|
0.3400
|
0.3200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/03/21
|
24/08/21
|
28/03/22
|
23/08/22
|
22/03/23
|
16/08/23
|
16/08/23
|
20/03/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
32,181
|
41,789
|
45,764
|
-
|
20,916
|
28,414
|
34,683
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
3,662
|
2,921
|
5,865
|
-
|
4,656
|
6,237
|
8,161
|
ROE (net income / shareholders' equity)
|
-
|
3.86%
|
-2.71%
|
0.9%
|
-
|
5.88%
|
6.93%
|
7.96%
|
ROA (Net income/ Total Assets)
|
-
|
2.85%
|
-2.33%
|
0.7%
|
-
|
3.08%
|
3.87%
|
4.33%
|
Assets
1 |
-
|
-605,613
|
45,998
|
54,639
|
-
|
78,243
|
82,229
|
94,934
|
Book Value Per Share
2 |
-
|
17.80
|
12.90
|
14.40
|
-
|
16.50
|
17.90
|
19.70
|
Cash Flow per Share
2 |
-
|
1.680
|
1.110
|
1.880
|
-
|
1.570
|
1.940
|
2.220
|
Capex
1 |
-
|
37.6
|
502
|
40.2
|
-
|
187
|
209
|
221
|
Capex / Sales
|
-
|
0.19%
|
1.64%
|
0.09%
|
-
|
0.3%
|
0.29%
|
0.26%
|
Announcement Date
|
25/11/20
|
29/03/21
|
28/03/22
|
22/03/23
|
20/03/24
|
-
|
-
|
-
|
Last Close Price
24.62
CNY Average target price
40.01
CNY Spread / Average Target +62.51% Consensus |
1st Jan change
|
Capi.
|
---|
| -29.67% | 10.84B | | -32.21% | 15.27B | | -28.54% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -1.17% | 4.69B | | +52.19% | 4.29B | | -14.86% | 3.33B | | -6.93% | 3.01B | | -2.58% | 2.8B |
Other Drug Retailers
|